A Mid-Cap Opportunity In “Wet AMD”
The company’s drug for wet AMD had proven to help with the disorder, and thus it seems highly likely it will be approved.
Mid-Cap Opportunity
The company’s drug for wet AMD had proven to help with the disorder, and thus it seems highly likely it will be approved.